PT Itama Ranoraya Tbk (IDX:IRRA)

Indonesia · Delayed Price · Currency is IDR

358.00

-18.00 (-4.79%)

Jun 22, 2026, 10:54 AM WIB

-21.15% (1Y)

Market Cap	566.94B -10.0%
Revenue (ttm)	1.10T +3.1%
Net Income	65.90B +11.2%
EPS	42.68 +8.6%
Shares Out	1.51B
PE Ratio	8.81
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	633,700
Open	376.00
Previous Close	376.00
Day's Range	358.00 - 376.00
52-Week Range	322.00 - 615.00
Beta	0.34
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 5, 2026

About PT Itama Ranoraya Tbk

PT Itama Ranoraya Tbk wholesale trades in laboratory and pharmaceutical equipment, and medical devices for humans in Indonesia. It offers in vitro diagnostics products comprising rapid test, serology, glucose diagnostic, NAPZA test, and clinical laboratory; medical imaging products, including bone densitometer, C-arm, flat panel digital detector, mobile and stationary x-ray, and mammography; nefrology, blood and transfusion, orthopedic, radiotherapy, and surgical products; and hospital supplies and hospital kitchen equipment. The company also p... [Read more]

Industry Medical Distribution

Sector Healthcare

Founded 1988

Employees 209

Stock Exchange Indonesia Stock Exchange

Ticker Symbol IRRA

Full Company Profile

Financial Performance

In 2025, PT Itama Ranoraya Tbk's revenue was 1.10 trillion, an increase of 12.55% compared to the previous year's 977.49 billion. Earnings were 65.53 billion, an increase of 23.03%.

Financial Statements